PET/CT (FDG) is an advanced nuclear medicine technique used to visualize the metabolic activity of cancer cells. Radioactive glucose, known as FDG, is administered to the body to observe glucose consumption by cells. Since rapidly dividing tumor cells consume FDG at a high rate, these areas stand out in the image.
This method is used for:
Cancer diagnosis
Metastasis screening
Evaluating response to treatment
Radiotherapy planning
PET/CT provides whole-body imaging and increases diagnostic accuracy. Results can usually be obtained the next day.
Special English reports are prepared for international patients, and the process is managed with language support.
